Close Menu

BERLIN (GenomeWeb) – Bladder cancer has a high survival rate when detected early and removed by surgery but there is no good treatment, and poor survival, once it has become invasive.

In addition, current molecular tests for bladder cancer do not perform well, so the diagnostic gold standard remains cystoscopy, where a thin, lighted tube with a lens called a cytoscope is inserted into the urethra and bladder.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.